Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
IPAH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.05
N/A
NA
vs NA
Q4.05
N/A
NA
vs NA
Q1.06
N/A
NA
vs NA
Q2.06
N/A
NA
vs NA
Q3.06
N/A
NA
vs NA
Q4.06
N/A
NA
vs NA
Q1.07
N/A
NA
vs NA
Q2.07
N/A
NA
vs NA
Q3.07
N/A
NA
vs NA
Q4.07
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q3.05
+61%
14.5M vs 9.1M
Q4.05
+83%
16.2M vs 8.8M
Q1.06
+51%
16.1M vs 10.7M
Q2.06
+45%
16.5M vs 11.4M
Q3.06
+57%
22.8M vs 14.5M
Q4.06
+8%
17.5M vs 16.2M
Q1.07
+24%
19.9M vs 16.1M
Q2.07
-7%
15.4M vs 16.5M
Q3.07
-22%
17.7M vs 22.8M
Q4.07
-7%
16.2M vs 17.5M
Return on Equity
QoQ
Q3.05
-2%
-0.02
vs -0.02
Q4.05
+3%
0.03
vs -0.02
Q1.06
-7%
-0.07
vs 0.03
Q2.06
-11%
-0.11
vs -0.07
Q3.06
+6%
0.06
vs -0.11
Q4.06
-18%
-0.18
vs 0.06
Q1.07
-9%
-0.09
vs -0.18
Q2.07
-85%
-0.85
vs -0.09
Q3.07
-136%
-1.36
vs -0.85
Q4.07
+206%
2.06
vs -1.36
Institutionnal Ownership
N/A
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Q4.25
NA
NA
vs NA
NA
Quote Panel
Key Metrics
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Relative Strength
IPAH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. The company supplies its medicines to major retailers, wholesalers, managed care organizations, and national distributors. The company was founded in 1984 and is based in Hauppauge, New York.
OTC
Relative Strenght
Volume Buzz
-86%
Earning Acce
No
Dist 52w H.
0%